Medicale Corp
MCLE
Other OTC0.07
USD
+0.05
- -
Medicale Corp
MCLE
(Other OTC)
Recent
price
0.07
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Medicale Corp (MCLE) develops and commercializes innovative medical devices and technologies focused on advanced diagnostics, therapeutic solutions, and patient monitoring systems for the healthcare sector. The company offers a portfolio of core products including proprietary imaging scanners for early disease detection, wearable biosensors for real-time vital sign tracking, minimally invasive surgical instruments, and AI-powered software platforms for data analytics and predictive healthcare outcomes; these solutions target hospitals, clinics, ambulatory care centers, and telemedicine providers across North America, Europe, and Asia. Founded in 2012 and headquartered in Irvine, California, Medicale Corp operates through specialized business segments in medical imaging, digital health, and precision medicine, with key subsidiaries handling regulatory compliance and international distribution. In the past year, Medicale Corp completed a significant strategic acquisition of a European diagnostics firm to expand its AI analytics capabilities and entered a major partnership with a leading U.S. hospital network for pilot deployments of its biosensor technology. The company also secured a $75 million funding round in late 2024 led by venture capital firms specializing in health tech, enabling accelerated R&D for next-generation robotic-assisted surgery tools launched in early 2025. These developments mark a shift toward global expansion, including new manufacturing facilities in Asia and a reorganized executive team to support scaled operations.